Therapeutic Research in Multiple Myeloma
- Conditions
- Multiple Myeloma
- Interventions
- Other: No drugs are involved
- Registration Number
- NCT00572338
- Lead Sponsor
- University of Arkansas
- Brief Summary
The purpose of this study is to learn how myeloma cells grow and become a cancer, how to distinguish them from normal cells and how to eliminate these cells selectively.
- Detailed Description
Participating in this study will require that blood and bone marrow samples be obtained as a part of the diagnostic work-up or follow-up of your multiple myeloma. Bone marrow/peripheral blood/tissue samples will be collected for research purposes, as well as testing for genetic traits of Castleman's disease if you consent to this study. In addition, data will be collected including demographic information gathered from your medical record, including gender, date of birth, ethnicity, date of diagnosis, laboratory and pathology results, treatment protocols, dates of relapses, subsequent treatment protocols, and current treatments and medications.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 6388
- Any subject evaluated for a MIRT protocol
- Subjects who have not been evaluated for a MIRT protocol
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description patients with myeloma/related diseases No drugs are involved -
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Arkansas for Medical Sciences/MIRT
🇺🇸Little Rock, Arkansas, United States